These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9075163)

  • 1. Hepatitis B vaccination.
    Paynter HE; Clarke J; McArley A; Williams AJ
    Nephrol Dial Transplant; 1997 Mar; 12(3):623-4. PubMed ID: 9075163
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B vaccination: time for a booster?
    Shopper T
    LDA J; 1992; 51(3):5-6. PubMed ID: 9518764
    [No Abstract]   [Full Text] [Related]  

  • 3. [Active hepatitis B vaccination in ulcerative colitis treated with azathioprine].
    Hinrichsen H; Fölsch UR
    Internist (Berl); 1999 Mar; 40(3):327-8. PubMed ID: 10205763
    [No Abstract]   [Full Text] [Related]  

  • 4. [HBs antigenemia and vaccination against hepatitis B virus: attention to chronology of markers].
    Beaulieu S; Lopez Y; Eugène C
    Presse Med; 2000 Oct; 29(32):1762-3. PubMed ID: 11098272
    [No Abstract]   [Full Text] [Related]  

  • 5. National Advisory Committee on Immunization (NACI). Revised guidelines for booster vaccination against hepatitis B.
    Can Commun Dis Rep; 1992 Aug; 18(16):121-2. PubMed ID: 1290997
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis B immunity and vaccination coverage among young adult males in the Air Force in South Brazil.
    Passos AM; Treitinger A; Spada C
    Vaccine; 2011 Nov; 29(49):9284-8. PubMed ID: 21722687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatitis B vaccination in patients on chronic hemodialysis].
    Kovacić V; Sain M; Vukman V
    Lijec Vjesn; 2003; 125(5-6):156-8. PubMed ID: 14533468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B vaccination: to boost or not to boost?
    Kao JH; Chen DS
    Lancet; 2005 Oct 15-21; 366(9494):1337-8. PubMed ID: 16226597
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunological response to hepatitis B vaccine in polytransfused thalassemic patients.
    Alavian SM; Tabatabaei SV
    Pediatr Hematol Oncol; 2010 May; 27(4):324-5; author reply 326-7. PubMed ID: 20426525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Booster hepatitis B vaccination not necessary for long-term protection in children immunised with hexavalent vaccines.
    Romanò L; Zanetti AR
    J Prev Med Hyg; 2011 Jun; 52(2):45-6. PubMed ID: 21842704
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of hepatitis B infections: vaccination and its limitations.
    Leroux-Roels G; Cao T; De Knibber A; Meuleman P; Roobrouck A; Farhoudi A; Vanlandschoot P; Desombere I
    Acta Clin Belg; 2001; 56(4):209-19. PubMed ID: 11603250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The impact of hepatitis B vaccination in Italy and the advent of novel recombinant vaccines containing pre-S1 and pre-S2].
    Romanò L; Biffi R; Bianchi S; Zanetti A
    Ann Ig; 2002; 14(3 Suppl 3):19-25. PubMed ID: 12389407
    [No Abstract]   [Full Text] [Related]  

  • 13. Universal hepatitis B vaccination: killing 2 birds with 1 stone.
    Kao JH; Chen DS
    Am J Med; 2008 Dec; 121(12):1029-31. PubMed ID: 19028192
    [No Abstract]   [Full Text] [Related]  

  • 14. No seroconversion after hepatitis B immunization.
    Cherian T; John TJ
    Indian Pediatr; 1997 Jun; 34(6):555-6. PubMed ID: 9357216
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of C4A deficiency on nonresponse to HBsAg vaccination: a new immune response gene.
    Milich DR
    J Hepatol; 2002 Sep; 37(3):396-9. PubMed ID: 12175637
    [No Abstract]   [Full Text] [Related]  

  • 16. Declining antibody levels after hepatitis B vaccination in Down syndrome: A need for booster vaccination?
    Eijsvoogel NB; Hollegien MI; Bok VLA; Derksen Lubsen AG; Dikken FPJ; Leenders SACAP; Pijning A; Post E; Wojciechowski M; Hilbink M; de Vries E
    J Med Virol; 2017 Sep; 89(9):1682-1685. PubMed ID: 28322457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of CHO cell derived hepatitis B vaccine in children and adults.
    Qureshi H; Ahsan T; Memon M
    J Pak Med Assoc; 2002 Mar; 52(3):128-9. PubMed ID: 12071069
    [No Abstract]   [Full Text] [Related]  

  • 18. Intradermal hepatitis B vaccination: five-year follow-up.
    Leonardi S; Barone P; Musumeci S
    Pediatr Infect Dis J; 1995 Aug; 14(8):716-7. PubMed ID: 8532435
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel strategies in vaccine design: can nanocapsules help prevent and treat hepatitis B?
    Gehring S; Pietrzak-Nguyen A; Fichter M; Landfester K
    Nanomedicine (Lond); 2017 Jun; 12(11):1205-1207. PubMed ID: 28517963
    [No Abstract]   [Full Text] [Related]  

  • 20. Mathematical model of the antibody response to hepatitis B vaccines: implications for reduced schedules.
    Wilson JN; Nokes DJ; Medley GF; Shouval D
    Vaccine; 2007 May; 25(18):3705-12. PubMed ID: 17306427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.